Filter
6632
Filtered Results: 6632
Text search:
intervention
guide
Featured
Recommendations
695
New Publications
1726
Language
Document type
No document type
3696
Guidelines
957
Studies & Reports
950
Manuals
448
Strategic & Response Plan
279
Training Material
155
Fact sheets
69
Situation Updates
40
Resource Platforms
15
Brochures
10
Infographics
8
Online Courses
4
App
1
Countries / Regions
Global
251
India
224
Kenya
216
South Africa
130
Ethiopia
128
Nigeria
124
Uganda
124
Latin America and the Carribbean
103
Sierra Leone
100
Congo, Democratic Republic of
100
Malawi
98
Nepal
92
Western and Central Europe
89
Africa
88
Tanzania
86
Zambia
83
Myanmar / Burma
83
Rwanda
81
Liberia
81
Bangladesh
73
Senegal
70
Ukraine
66
Ghana
65
Syria
62
Burkina Faso
60
Haiti
59
Philippines
51
Benin
45
Eastern Europe
45
Namibia
44
West and Central Africa
39
Lesotho
37
South–East Asia Region
37
Cameroon
35
Zimbabwe
35
Russia
34
South Sudan
33
Guinea
32
East and Southern Africa
32
Mozambique
30
Asia
28
Cambodia
25
Middle East and North Africa
25
Madagascar
24
Colombia
22
Germany
22
Botswana
22
Brazil
20
Indonesia
20
Central African Republic
19
Pakistan
19
Yemen
18
Eastern Europe and Central Asia
17
Lebanon
17
Mali
17
Thailand
14
Afghanistan
14
Western Pacific Region
14
Sudan
14
Eswatini/ Swaziland
14
Jordan
13
Vietnam
13
Niger
12
Somalia
12
Venezuela
11
Côte d’Ivoire / Ivory Coast
11
Laos
9
USA
9
Chad
9
Turkey
8
Sri Lanka
8
Georgia
8
Togo
7
Chile
7
Peru
7
Argentina
7
Moldova
7
Iraq
7
Ecuador
7
Tajikistan
6
China
6
Portugal
6
Angola
6
Albania
5
Burundi
5
Paraguay
5
North America
5
United Kingdom
5
Southern Africa
5
Papua New Guinea
5
North Macedonia
4
El Salvador
4
Kyrgyzstan
4
Morocco
4
Spain
4
Iran
3
Canada
3
Armenia
3
Jamaica
3
Japan
3
France
3
Belarus
3
Bosnia and Herzegovina
3
Bolivia
3
Libya
3
Bhutan
3
Switzerland
2
Timor Leste/ East Timor
2
Mexico
2
Serbia
2
Kazakhstan
2
Fiji
2
Singapore
2
Estonia
2
Italy
2
Guinea-Bissau
2
Hungary
2
Gabon
2
Turkmenistan
2
Belgium
2
Tunisia
2
Nicaragua
2
Romania
2
Greece
2
Palestine
2
Guatemala
2
North Korea
1
Gambia
1
Congo-Brazzaville
1
Vanuatu
1
Qatar
1
Bulgaria
1
Mauritania
1
Dominican Republic
1
Croatia
1
Saudi Arabia
1
Luxembourg
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Azerbaijan
1
Israel
1
Djibouti
1
Egypt
1
Poland
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
2380
Clinical Guidelines
566
Women & Child Health
465
Public Health
419
Key Resources
356
Capacity Building
149
Pharmacy & Technologies
53
Annual Report MEDBOX
2
Toolboxes
Mental Health
621
HIV
481
COVID-19
471
TB
308
Disability
274
Caregiver
263
Planetary Health
214
AMR
210
Rapid Response
201
Conflict
178
NTDs
137
Ebola
136
NCDs
120
Refugee
107
Global Health Education
106
Pharmacy
95
Natural Hazards
94
Zika
41
Cholera
40
Health Financing Toolbox
36
Polio
29
Social Ethics
28
Specific Hazards
22
Typhoon
5
South Sudan
2
Health Financing
1
The world is not on track to end the AIDS pandemic. New infections are rising and AIDS deaths are continuing in too many communities. This report reveals why: inequalities are holding us back. In frank terms, the report calls the world’s attention to the painful reality that dangerous inequalities...
This brief advocacy document highlights the burden, risks and prevention of injuries and violence, which took the lives of 4.4 million people in 2019 and constitute 8% of all deaths. Among the injury-related causes of death include road traffic crashes, drowning, falls, burns, poisoning and violence...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
